![]() Washington Post | Pfizer shares at risk following heart-drug failure Reuters - By Ransdell Pierson. NEW YORK (Reuters) - With the sudden failure of torcetrapib Pfizer Inc.'s most important experimental product financial analysts predict shares of the world's largest drugmaker could ... Pfizer Halts testing Of New Drug Pfizer ups 2006 earnings guidance; to expand pipeline |